AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Tuberculosis (TB) Market Spotlight 2019-2027: GlaxoSmithKline Leads Industry Sponsors with the Highest Overall Number of Clinical Trials - ResearchAndMarkets.com

November 4, 2019

DUBLIN--(BUSINESS WIRE)--Nov 4, 2019--

The “Market Spotlight: Tuberculosis (TB)” report has been added to ResearchAndMarkets.com’s offering.

This Market Spotlight report covers the Tuberculosis (TB) market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability of success, patent information, a 10-year disease incidence forecast, and licensing and acquisition deals.

Key Takeaways

Key Topics Covered:

OVERVIEW

KEY TAKEAWAYS

DISEASE BACKGROUND

TREATMENT

EPIDEMIOLOGY

MARKETED DRUGS

PIPELINE DRUGS

RECENT EVENTS AND ANALYST OPINION

Pretomanid for tuberculosis (June 6, 2019)

Pretomanid for tuberculosis (June 4, 2019)

Pretomanid for tuberculosis (April 18, 2019)

Pretomanid for tuberculosis (October 26, 2018)

M72/AS01E for tuberculosis (September 25, 2018)

KEY UPCOMING EVENTS

KEY REGULATORY EVENTS

Pretomanid Approval For Resistant TB: With Regulatory Flexibility Comes Usage Restrictions

Pretomanid Gets Panel Endorsement As Part Of Regimen, Not Individual Molecule, For Treatment-Resistant Tuberculosis

PROBABILITY OF SUCCESS

LICENSING AND ASSET ACQUISITION DEALS

BioNTech Gets Gates Foundation Funding For HIV, TB Drug Discovery

Deals Shaping The Medical Industry, December 2018

Deals Shaping The Medical Industry, October 2018

PARENT PATENTS

CLINICAL TRIAL LANDSCAPE

Sponsors by status

Sponsors by phase

BIBLIOGRAPHY

Prescription information

APPENDIX

For more information about this report visit https://www.researchandmarkets.com/r/9lb60r

View source version on businesswire.com:https://www.businesswire.com/news/home/20191104005623/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 11/04/2019 10:32 AM/DISC: 11/04/2019 10:32 AM

http://www.businesswire.com/news/home/20191104005623/en